GlassScript

Biomerieux INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.6Mgeneral payments (2019-2025)
$231Kresearch payments (2019-2025)
2,819clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $192K
2020 $66K
2021 $154K
2022 $144K
2023 $373K
2024 $243K
2025 $431K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Infectious Disease $261K
Emergency Medicine $257K
Critical Care Medicine (Internal Medicine) $196K
Critical Care Medicine (Anesthesiology) $111K
Pulmonary Disease $103K
Pediatric Infectious Diseases $83K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Daniel Feinstein Pinehurst, NC Critical Care Medicine (Internal Medicine) $181,077.56
Louis Guzzi Orlando, FL Critical Care Medicine (Anesthesiology) $95,089.25
V Reddy Nashville, TN Thoracic Surgery (Cardiothoracic Vascular Surgery) $57,902.94
Devendra Amin Clearwater, FL Pulmonary Disease $53,481.23
Nicole Haig East Point, GA Emergency Medicine $53,267.30
Andrew Meltzer Washington, DC Emergency Medicine $50,777.62
Javeed Siddiqui Roseville, CA Infectious Disease $45,248.17
Denver Niles Houston, TX Pediatric Infectious Diseases $40,456.60
Jeniel Parmar Boca Raton, FL Emergency Medicine $35,784.89
Trevor Vanschooneveld Omaha, NE Infectious Disease $34,496.55

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.